Literature DB >> 19727567

Non-vitrectomizing surgery for idiopathic macular pucker using a 25-gauge synergetics high-flow infusion with a 27-gauge light (Photon II, Synergetics USA, Inc.).

Cesare Mariotti1, Francesca Viti, Piergiorgio Neri.   

Abstract

To describe a case of macular pucker treated by non-vitrectomizing vitreoretinal surgery using a 25-gauge high-flow infusion cannula with a 27-gauge illumination source (Photon II; both from Synergetics USA Inc., O'Fallon, MO). A 42-year-old man complaining of visual reduction and metamorphopsia was referred to the Vitreoretinal Surgery Unit, where he underwent full ophthalmic examination. Best corrected visual acuity (BCVA) at baseline was 0.5 in the left eye (LE) and 1.0 in the right eye. He was diagnosed with epiretinal membrane (ERM) in the LE. The surgical procedure envisaged two-port sclerotomy, one for the infusion line of the 27-gauge Photon II light source, the other for the 25-gauge trocar in the superotemporal quadrant. The ERM was removed with a 25-gauge disposable forceps. The infusion line was placed for safety in the event of additional intraocular pressure being needed, but was not required. The 27-gauge light source afforded good visualization of the posterior pole and the ERM. At 12 months, the patient's BCVA had improved to 1.0, and his cataract has not progressed. A 25-gauge infusion line used with the photon illumination may further improve non-vitrectomizing surgery, minimizing risk and optimizing outcome. Further trials are required to validate these preliminary observations.

Entities:  

Mesh:

Year:  2009        PMID: 19727567     DOI: 10.1007/s10792-009-9322-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  15 in total

1.  Microsurgical instrumentation for vitrectomy: Part II.

Authors:  C C Wang; S Charles
Journal:  J Clin Eng       Date:  1984 Jan-Mar

2.  Intraoperative sclerotomy-related retinal breaks for macular surgery, 20- vs 25-gauge vitrectomy systems.

Authors:  Richard Scartozzi; Amr S Bessa; Omesh P Gupta; Carl D Regillo
Journal:  Am J Ophthalmol       Date:  2006-09-01       Impact factor: 5.258

3.  25-gauge macular surgery: results and complications.

Authors:  Fabio Patelli; Paolo Radice; Giulio Zumbo; Giampiero Frisone; Giuseppe Fasolino
Journal:  Retina       Date:  2007 Jul-Aug       Impact factor: 4.256

4.  Vitreoretinal juncture--simple epiretinal membranes.

Authors:  R Y Foos
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974-01-28

5.  Nonvitrectomizing vitreous surgery for epiretinal membrane long-term follow-up.

Authors:  Miki Sawa; Masahito Ohji; Shunji Kusaka; Hirokazu Sakaguchi; Fumi Gomi; Yoshihiro Saito; Yasuo Tano
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

6.  Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.

Authors:  Michael S Ibarra; Martin Hermel; Jonathan L Prenner; Tarek S Hassan
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

7.  Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases.

Authors:  Tetsuhiko Okuda; Akira Nishimura; Akira Kobayashi; Kazuhisa Sugiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-05-19       Impact factor: 3.117

8.  Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease.

Authors:  Rohit R Lakhanpal; Mark S Humayun; Eugene de Juan; Jennifer I Lim; Lawrence P Chong; Tom S Chang; Michael Javaheri; Gildo Y Fujii; Aaron C Barnes; Terry J Alexandrou
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

9.  Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery.

Authors:  Gildo Y Fujii; Eugene De Juan; Mark S Humayun; Tom S Chang; Dante J Pieramici; Aaron Barnes; David Kent
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

10.  Untoward outcomes in 25-gauge versus 20-gauge vitreoretinal surgery.

Authors:  Saad Shaikh; Son Ho; Preston P Richmond; John C Olson; C Durham Barnes
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.